Fortress Biotech CFO awarded 2,967 ESPP shares
Fortress Biotech, Inc. Chief Financial Officer David Jin acquired 2,967 shares of common stock at $2.176 per share through the company’s Employee Stock Purchase Plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Fortress Biotech, Inc. Chief Financial Officer David Jin acquired 2,967 shares of common stock at $2.176 per share through the company’s Employee Stock Purchase Plan. This grant was reported as exempt under Rule 16b-3(d) and Rule 16b-3(c). After the transaction, he holds 1,251,571 shares in total, including 1,230,000 shares underlying deferred restricted stock units, so the new purchase represents a small portion of his overall position.
Insider Trade Summary
Grant/Award: 2,967 shares
Grant/Award
1 txn
Insider
Jin David
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 | 2,967 | $2.176 | $6K |
Holdings After Transaction:
Common Stock, par value $0.001 — 1,251,571 shares (Direct)
Footnotes (2)
- F1. The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2. Total holdings include 1,230,000 shares underlying deferred restricted stock units.
Key Figures
Shares acquired: 2,967 shares
Acquisition price: $2.176 per share
Total shares after transaction: 1,251,571 shares
+1 more
4 metrics
Shares acquired
2,967 shares
Employee Stock Purchase Plan grant to CFO David Jin
Acquisition price
$2.176 per share
Price for ESPP shares acquired on 2026-04-01
Total shares after transaction
1,251,571 shares
CFO David Jin’s holdings following the grant
Deferred RSU underlying shares
1,230,000 shares
Included within total holdings as deferred restricted stock units
Key Terms
Employee Stock Purchase Plan, Rule 16b-3(d), Rule 16b-3(c), deferred restricted stock units
4 terms
Employee Stock Purchase Plan financial
"an acquisition of shares under the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(d) regulatory
"a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
deferred restricted stock units financial
"Total holdings include 1,230,000 shares underlying deferred restricted stock units"
Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Fortress Biotech (FBIO) report for its CFO?
Fortress Biotech reported that CFO David Jin acquired 2,967 shares of common stock through the company’s Employee Stock Purchase Plan. The shares were obtained at a price of $2.176 per share and were characterized as a grant or award acquisition rather than an open-market purchase.
What is notable about the rules cited for the Fortress Biotech (FBIO) CFO’s transaction?
The filing notes that the CFO’s acquisition under the Employee Stock Purchase Plan was exempt under Rule 16b-3(d) and Rule 16b-3(c). These provisions generally cover board-approved, issuer-sponsored plans, framing the transaction as routine compensation-related activity rather than discretionary market trading.
AI-generated analysis. How Rhea-AI works. Not financial advice.
